Skip to main content

Table 2 Trial primary effectiveness outcomes

From: Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study

Primary effectiveness outcomes

Clopidogrel with Aspirin (n = 93)

Clopidogrel with Indobufen (n = 89)

Effect Variable

Value (95% CI)

p

Ending event(%)

6(6.5)

0(0)

Hazard ratio

0.94(0.89–0.99)

0.029

Modified Rankin scale score at 90 days - IQR

1(1–2)

0(0–0)

Common odds ratio

3.629(1.874–7.036)

< 0.0001

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us